ArticleACS medicinal chemistry letters2021

Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds.

Brandon A Vara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.